Change history 11 December 2024 “An overview of approaches to estimating seasonal influenza vaccine effectiveness (VE)” should has been processed as the section heading References Shaw AR. Universal influenza vaccine: the holy grail? Expert Rev Vaccines. 2012;11(8):923–7. Article CAS PubMed ...
Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023 Vaccine, 42 (2024), pp. 1878-1882 View PDFView articleView in ScopusGoogle Scholar [8] L.A. Grohskopf, L.H. Blanton, J.M. Ferdinan...
P-51. Influenza Vaccine Effectiveness in Ambulatory Care Settings among Pregnant Persons in the 2023-2024 Influenza Season doi:10.1093/ofid/ofae631.258BACKGROUND. Despite increased risk of influenza-associated complications in pregnant people, influenza vaccination coverage has decreased in recent seasons ...
1 Protection that can be as fierce as flu Help protect your patients against flu with FLUMIST—backed by years of vaccine effectiveness data, comparable to IIV1-12,*† See the VE data Help increase vaccine uptake See how to administer Order 2024-25 doses today Recommended as an option ...
The objective of this study was to provide an estimate of influenza vaccine effectiveness (VE) against influenza-associated hospitalization in children in Hong Kong during an A(H3N2) epidemic in June-November 2023. Access through your organization Check access to the full text by signing in ...
Seasonal influenza vaccine effectiveness, 2004–2018 https://www.cdc.gov/flu/vaccines-work/past-seasons-estimates (CDC, 2019). Erbelding, E. J. et al. A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases. J. Infect. Dis. 218, 347...
Received a total of 2 or more doses of any seasonal influenza vaccine ≥4 weeks apart before July 1, 2024: Administer a single 0.5 mL dose of Fluarix or Flulaval.Infants and Children 6 through 35 Months of Age (Fluzone) IM For infants and children 6 through 35 months of age, 0.25 ...
Oct 23, 2024 0 0 Gerontology & Geriatrics Study finds RSV vaccine highly effective in protecting older adults against severe disease, hospitalization and death A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV—short for...
Influenza vaccine effectiveness by time since vaccination (days) using mandatory reported California influenza laboratory and immunization data, October 2023–March 2024 METHODS. We included influenza laboratory surveillance data for all persons aged ≥6 months during October 1, 2023–March 31, 2024, ...
The global influenza vaccine market size was valued at USD 7.91 billion in 2023 and is expected to grow at a CAGR of 6.98% from 2024 to 2030